Synergistic effects of biosynthesized gold nanoparticles with curcumin on motor, inflammatory, and oxidative parameters in a Parkinson's disease model.
Paulo Cesar Lock Silveira, Ligia Milanez Venturini, Gustavo de Bem Silveira, Igor Ramos Lima, Camila da Costa, Gabrielli Martins, Laura de Roch Casagrande, Ellen De Pieri, Paulo Emilio Feuser, Yaodong Gu, Ricardo Andrez Machado-de-Ávila, Anand Thirupathi
{"title":"Synergistic effects of biosynthesized gold nanoparticles with curcumin on motor, inflammatory, and oxidative parameters in a Parkinson's disease model.","authors":"Paulo Cesar Lock Silveira, Ligia Milanez Venturini, Gustavo de Bem Silveira, Igor Ramos Lima, Camila da Costa, Gabrielli Martins, Laura de Roch Casagrande, Ellen De Pieri, Paulo Emilio Feuser, Yaodong Gu, Ricardo Andrez Machado-de-Ávila, Anand Thirupathi","doi":"10.1177/08853282251409687","DOIUrl":null,"url":null,"abstract":"<p><p>Parkinson's disease is a progressive and irreversible neurodegenerative disease, whose main characteristic is the death of dopaminergic neurons. The animal model of Parkinsonism with reserpine has been used to mimic the consequences of Parkinson's disease. The use of gold nanoparticles in the treatment of several diseases arises due to their evidence of promising antioxidant and anti-inflammatory properties. Curcumin, in turn, presents neuroprotective activity in neurodegenerative diseases by reducing both inflammatory activity and oxidative stress in models of Parkinson's disease. This article seeks to understand the effects of the use of gold nanoparticles biosynthesized with curcumin in an experimental model of Parkinson's disease with reserpine. C57BL/6 mice were used, divided into five groups: I. Control; II. Parkinson's disease; III. Parkinson's disease + Gold nanoparticles; IV. Parkinson's disease + Curcumin; V. Parkinson's disease + Gold nanoparticles biosynthesized with curcumin. Mice were subjected to subcutaneous induction with reserpine, and treatments began 24 h after administration. Seven treatments were applied at 24-h intervals via the intranasal route. After the last treatment, behavioral tests were conducted, followed by euthanasia and removal of brain structures. The combined treatments demonstrated potential neuroprotective effects, reversing inflammatory and oxidative processes and partially reversing Parkinsonian behavior. Together, these therapies potentiated their effects, leading to near-complete reversal of reserpine-induced damage.</p>","PeriodicalId":15138,"journal":{"name":"Journal of Biomaterials Applications","volume":" ","pages":"134-148"},"PeriodicalIF":2.4000,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Biomaterials Applications","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1177/08853282251409687","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/12/23 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Parkinson's disease is a progressive and irreversible neurodegenerative disease, whose main characteristic is the death of dopaminergic neurons. The animal model of Parkinsonism with reserpine has been used to mimic the consequences of Parkinson's disease. The use of gold nanoparticles in the treatment of several diseases arises due to their evidence of promising antioxidant and anti-inflammatory properties. Curcumin, in turn, presents neuroprotective activity in neurodegenerative diseases by reducing both inflammatory activity and oxidative stress in models of Parkinson's disease. This article seeks to understand the effects of the use of gold nanoparticles biosynthesized with curcumin in an experimental model of Parkinson's disease with reserpine. C57BL/6 mice were used, divided into five groups: I. Control; II. Parkinson's disease; III. Parkinson's disease + Gold nanoparticles; IV. Parkinson's disease + Curcumin; V. Parkinson's disease + Gold nanoparticles biosynthesized with curcumin. Mice were subjected to subcutaneous induction with reserpine, and treatments began 24 h after administration. Seven treatments were applied at 24-h intervals via the intranasal route. After the last treatment, behavioral tests were conducted, followed by euthanasia and removal of brain structures. The combined treatments demonstrated potential neuroprotective effects, reversing inflammatory and oxidative processes and partially reversing Parkinsonian behavior. Together, these therapies potentiated their effects, leading to near-complete reversal of reserpine-induced damage.
期刊介绍:
The Journal of Biomaterials Applications is a fully peer reviewed international journal that publishes original research and review articles that emphasize the development, manufacture and clinical applications of biomaterials.
Peer-reviewed articles by biomedical specialists from around the world cover:
New developments in biomaterials, R&D, properties and performance, evaluation and applications
Applications in biomedical materials and devices - from sutures and wound dressings to biosensors and cardiovascular devices
Current findings in biological compatibility/incompatibility of biomaterials
The Journal of Biomaterials Applications publishes original articles that emphasize the development, manufacture and clinical applications of biomaterials. Biomaterials continue to be one of the most rapidly growing areas of research in plastics today and certainly one of the biggest technical challenges, since biomaterial performance is dependent on polymer compatibility with the aggressive biological environment. The Journal cuts across disciplines and focuses on medical research and topics that present the broadest view of practical applications of biomaterials in actual clinical use.
The Journal of Biomaterial Applications is devoted to new and emerging biomaterials technologies, particularly focusing on the many applications which are under development at industrial biomedical and polymer research facilities, as well as the ongoing activities in academic, medical and applied clinical uses of devices.